Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesan Arunagirinathan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Drug Safety|December 18, 2020
Efficacy and Cardiovascular Safety of Alpha Glucosidase InhibitorsNizam Ud Din Khwaja, Ganesan Arunagirinathan
Touchreviews in Endocrinology|January 25, 2023
Statin-related Muscle Toxicity: An Evidence-based ReviewMohammad S Jeeyavudeen, Joseph M Pappachan, Ganesan Arunagirinathan
Touchreviews in Endocrinology|June 14, 2023
Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle ModificationMatthias Li, Mohammad Sadiq Jeeyavudeen, Ganesan Arunagirinathan, et al.
International Journal of Hypertension|June 2, 2011
Management of hypertension and diabetes in obesity: non-pharmacological measuresJoseph M Pappachan, Elias C Chacko, Ganesan Arunagirinathan, et al.
World Journal of Diabetes|October 23, 2013
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and managementJoseph M Pappachan, George I Varughese, Rajagopalan Sriraman, et al.
World Journal of Diabetes|July 12, 2017
Diabetes mellitus and stroke: A clinical updateNyo Nyo Tun, Ganesan Arunagirinathan, Sunil K Munshi, et al.
Current Hypertension Reports|January 23, 2018
Pheochromocytomas and HypertensionJoseph M Pappachan, Nyo Nyo Tun, Ganesan Arunagirinathan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2020
Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetesEvgenia Foteinopoulou, Catriona A L Clarke, Rebecca J Pattenden, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Drug Safety|December 18, 2020
Efficacy and Cardiovascular Safety of Alpha Glucosidase InhibitorsNizam Ud Din Khwaja, Ganesan Arunagirinathan
Touchreviews in Endocrinology|January 25, 2023
Statin-related Muscle Toxicity: An Evidence-based ReviewMohammad S Jeeyavudeen, Joseph M Pappachan, Ganesan Arunagirinathan
Touchreviews in Endocrinology|June 14, 2023
Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle ModificationMatthias Li, Mohammad Sadiq Jeeyavudeen, Ganesan Arunagirinathan, et al.
International Journal of Hypertension|June 2, 2011
Management of hypertension and diabetes in obesity: non-pharmacological measuresJoseph M Pappachan, Elias C Chacko, Ganesan Arunagirinathan, et al.
World Journal of Diabetes|October 23, 2013
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and managementJoseph M Pappachan, George I Varughese, Rajagopalan Sriraman, et al.
World Journal of Diabetes|July 12, 2017
Diabetes mellitus and stroke: A clinical updateNyo Nyo Tun, Ganesan Arunagirinathan, Sunil K Munshi, et al.
Current Hypertension Reports|January 23, 2018
Pheochromocytomas and HypertensionJoseph M Pappachan, Nyo Nyo Tun, Ganesan Arunagirinathan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2020
Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetesEvgenia Foteinopoulou, Catriona A L Clarke, Rebecca J Pattenden, et al.
Pageof 1